Denali Therapeutics (DNLI)
Develops brain-penetrating therapies and commercializes AVLAYAH for Hunter syndrome.
$20.62
vs last close−0.98 (−4.55%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 43 days
EPS estimate
−$0.37
Revenue estimate
$12.2M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.67−$0.78−$0.72−$0.74−$0.73−$0.69−$0.68Pending
Estimate−$0.75−$0.71−$0.74−$0.76−$0.75−$0.73−$0.51−$0.37
Surprise+10.7%−9.9%+2.7%+2.6%+2.7%+5.5%−32.5%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported——————$3.6MPending
Estimate$12.8M$3.0M$5.6M$2.9M$3.1M$2.6M$2.2M$12.2M
Surprise——————+67.3%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | −$0.40 | — | — |
| Sep 2028 | −$0.43 | — | — |
| Jun 2028 | −$0.48 | — | — |
| Mar 2028 | −$0.51 | — | — |
| Dec 2027 | −$0.50 | — | — |
| Sep 2027 | −$0.57 | — | — |
| Jun 2027 | −$0.62 | — | — |
| Mar 2027 | −$0.62 | — | — |
| Dec 2026 | −$0.63 | — | — |
| Nov 2026 | −$0.37 | — | — |
| Aug 2026 | −$0.51 | −$0.68 | −32.5% |
| May 2026 | −$0.73 | −$0.69 | +5.5% |
| Feb 2026 | −$0.75 | −$0.73 | +2.7% |
| Nov 2025 | −$0.76 | −$0.74 | +2.6% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Sep 2017 | |||
| Dec 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | −$0.40 | — | — | $84.2M | — | — | — |
| Sep 2028 | −$0.43 | — | — | $74.1M | — | — | — |
| Jun 2028 | −$0.48 | — | — | $64.0M | — | — | — |
| Mar 2028 | −$0.51 | — | — | $54.2M | — | — | — |
| Dec 2027 | −$0.50 | — | — | $34.5M | — | — | — |
| Sep 2027 | −$0.57 | — | — | $30.3M | — | — | — |
| Jun 2027 | −$0.62 | — | — | $25.5M | — | — | — |
| Mar 2027 | −$0.62 | — | — | $22.3M | — | — | — |
| Dec 2026 | −$0.63 | — | — | $22.7M | — | — | — |
| Nov 5, 2026 | −$0.37 | — | — | $12.2M | — | — | — |
| Aug 6, 2026 | −$0.51 | −$0.68 | −32.5% | $2.2M | $3.6M | +67.3% | +0.4% |
| May 7, 2026 | −$0.73 | −$0.69 | +5.5% | $2.6M | — | — | −3.4% |
| Feb 26, 2026 | −$0.75 | −$0.73 | +2.7% | $3.1M | — | — | −1.1% |
| Nov 6, 2025 | −$0.76 | −$0.74 | +2.6% | $2.9M | — | — | −3.2% |
| Aug 11, 2025 | |||||||
| May 6, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 6, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 7, 2024 | |||||||
| Feb 27, 2024 | |||||||
| Nov 7, 2023 | |||||||
| Aug 8, 2023 | |||||||
| May 8, 2023 | |||||||
| Feb 27, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 8, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 28, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 3, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 7, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 12, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 9, 2018 | |||||||
| May 11, 2018 | |||||||
| Mar 19, 2018 | |||||||
| Sep 30, 2017 | |||||||
| Dec 8, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 |